Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.51 |
| ▸ | NPY1R | P25929 | 9/20 | 0.51 |
| ▸ | NPY2R | P49146 | 7/20 | 0.51 |
| ▸ | MC4R | P32245 | 4/20 | 0.49 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.43 |
| ▸ | FCER2 | P06734 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22485383 | 1.00 | NPY4R (0.51) | NPY4RNPY5RNPY1RNPY2RMC4R | |
| SCHEMBL22339062 | 0.94 | NPY4R (0.55) | NPY4RNPY5RNPY1RNPY2RMC4R | |
| SCHEMBL20046064 | 0.89 | MC4R (0.48) | NPY4RNPY5RNPY1RNPY2RMC4R | |
| SCHEMBL20045521 | 0.89 | MC4R (0.48) | NPY4RNPY5RNPY1RNPY2RMC4R | |
| SCHEMBL24114780 | 0.87 | NPY4R (0.49) | NPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL24919552 | 0.87 | NPY4R (0.57) | NPY4RNPY5RNPY1RNPY2RCALCRL | |
| SCHEMBL14811912 | 0.86 | MC4R (0.57) | MC4R | |
| SCHEMBL22339064 | 0.84 | MC4R (0.55) | MC4R | |
| SCHEMBL29697024 | 0.84 | KISS1R (0.45) | NPY4RNPY5RNPY1RNPY2RMC4R | |
| SCHEMBL30548763 | 0.84 | NPY4R (0.55) | NPY4RNPY5RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3704134-B1 | ANTIMICROBIAL TETRAPEPTIDES | DSM IP ASSETS BV (NL) | 2021-12-22 | — | — | EP | disclosed |
| US-20200308222-A1 | ANTIMICROBIAL TETRAPEPTIDES | DSM IP ASSETS B.V. (NL) | 2020-10-01 | — | — | US | disclosed |
| WO-2020161255-A1 | NOVEL METHOD FOR REDUCING HAIR GROWTH | DSM IP ASSETS B.V. (NL) | 2020-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308222-A1 | ANTIMICROBIAL TETRAPEPTIDES | VIP, CLPP, SGTA | NPY4R 2803/4885NPY5R 3428/4885NPY1R 3111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.